7UXL
Crystal structure of malaria transmission-blocking antigen Pfs48/45-6C variant in complex with human antibodies RUPA-44 and RUPA-29
7UXL の概要
| エントリーDOI | 10.2210/pdb7uxl/pdb |
| 分子名称 | RUPA-44 Fab Kappa chain, RUPA-44 Fab Heavy chain, Gametocyte surface protein P45/48, ... (6 entities in total) |
| 機能のキーワード | pfs48/45, human transmission-blocking antibodies, plasmodium falciparum, malaria, immune system |
| 由来する生物種 | Homo sapiens 詳細 |
| タンパク質・核酸の鎖数 | 5 |
| 化学式量合計 | 111470.65 |
| 構造登録者 | |
| 主引用文献 | Fabra-Garcia, A.,Hailemariam, S.,de Jong, R.M.,Janssen, K.,Teelen, K.,van de Vegte-Bolmer, M.,van Gemert, G.J.,Ivanochko, D.,Semesi, A.,McLeod, B.,Vos, M.W.,de Bruijni, M.H.C.,Bolscher, J.M.,Szabat, M.,Vogt, S.,Kraft, L.,Duncan, S.,Kamya, M.R.,Feeney, M.E.,Jagannathan, P.,Greenhouse, B.,Dechering, K.J.,Sauerwein, R.W.,King, C.R.,MacGill, R.S.,Bousema, T.,Julien, J.P.,Jore, M.M. Highly potent, naturally acquired human monoclonal antibodies against Pfs48/45 block Plasmodium falciparum transmission to mosquitoes. Immunity, 56:406-419.e7, 2023 Cited by PubMed Abstract: Malaria transmission-blocking vaccines (TBVs) aim to induce antibodies that interrupt malaria parasite development in the mosquito, thereby blocking onward transmission, and provide a much-needed tool for malaria control and elimination. The parasite surface protein Pfs48/45 is a leading TBV candidate. Here, we isolated and characterized a panel of 81 human Pfs48/45-specific monoclonal antibodies (mAbs) from donors naturally exposed to Plasmodium parasites. Genetically diverse mAbs against each of the three domains (D1-D3) of Pfs48/45 were identified. The most potent mAbs targeted D1 and D3 and achieved >80% transmission-reducing activity in standard membrane-feeding assays, at 10 and 2 μg/mL, respectively. Co-crystal structures of D3 in complex with four different mAbs delineated two conserved protective epitopes. Altogether, these Pfs48/45-specific human mAbs provide important insight into protective and non-protective epitopes that can further our understanding of transmission and inform the design of refined malaria transmission-blocking vaccine candidates. PubMed: 36792574DOI: 10.1016/j.immuni.2023.01.009 主引用文献が同じPDBエントリー |
| 実験手法 | X-RAY DIFFRACTION (2.86 Å) |
構造検証レポート
検証レポート(詳細版)
をダウンロード






